Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Deal follows multiple years of partnership, and an investment into PROPENSITY4 by Ashfield Engage in 2021.
May 10, 2022
By: Charlie Sternberg
Ashfield Engage, part of UDG Healthcare, has acquired PROPENSITY4—a smart data organization and leader in the healthcare insights and analytics arena, which integrates internal and external data assets and applies the right methodologies to derive detailed insight using proprietary analytical platforms that enables data-performance driven strategy. The acquisition follows multiple years of partnership, and an investment into PROPENSITY4 by Ashfield Engage in 2021. Ashfield made the decision to acquire the business following the success of multiple projects which have integrated the companies’ offering to provide clients with better approaches to omnichannel outreach and customer engagement on a global level. The acquisition will further Ashfield’s capability to apply analytical expertise to existing data to redesign programs which increase return on investment across commercial, patient engagement and medical affairs services, and improve patient outcomes. Christopher Savage, global head of strategy at Ashfield Engage, said, “Ashfield Engage works across the pharmaceutical industry, including top 20 pharma and emerging biotech, to establish and maintain exceptional relationships with the various healthcare stakeholders throughout the commercialization journey.” Savage continued, “Our customer engagement expertise, combined with the unparalleled data analytics we have gained through the acquisition of PROPENSITY4, will allow us to supersize our offering, ensuring we’re delivering the right message to the right customer at the right time in the right channel to maximize impact.” “We have already seen exceptional outcomes as a result of our collaborations. This shows that by applying analytical expertise to existing data, we can redesign engagement models which provide excellent results.” PROPENSITY4 uses proprietary analytical platforms alongside detailed market insight to inform engagement pathways with HCPs, which ultimately benefits patients. Sese Abhulimen, managing director at PROPENSITY4, said, “We’re excited to be joining an organization we already have a strong partnership with. PROPENSITY4 was created to move away from project-specific analytics to a big-picture approach, ensuring that data, analytics and insights are tied together to drive strategy across payers, patients and healthcare professionals. “We have always strived to be held accountable to the range of analytic outcomes we generate for our clients, and our partnership with Ashfield Engage has seen us not only further deliver on this goal but also provide exceptional ROI for our valued clients,” Abhulimen added.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !